malaria morbidity and mortality continue to go unchecked in many arts of the world. As efforts mount to develop an effective vaccine, it is readily apparent that little is know regarding the immune mechanisms mediating suppression of parasitemia in the infected host. Both cell- mediated immunity (CMI) and antibody-mediated immunity (AMI) against malaria are dependent upon the activation of CD4+alphabeta T cells. The goal of this proposal is to examine the function of different T cell activating signals on the development of protective immunity against blood-stage P chabaudi malaria in the novel model of knockout (KO) mice lacking genes for the particular molecule being studied. The activating signals to be examined are cytokines activating CD4+T helper cells through the IL-2 receptor, proinflammator cytokines (IFN-gamma, IL-12 and TNFalpha), co-stimulatory molecules (CD40L and CD28) and T cell receptors (TCRalphabeta and TCRgammazeta). The parameters of immunity to be assessed are parasitemia, outcome of infection, expansion of lymphocyte subsets, expression of activation markers, production of cytokines and macrophage activation markers, production of cytokines and macrophage activation. P. Chabaudi parasitemia is suppressed by cell- mediated or antibody mechanisms of immunity thereby providing the opportunity to evaluate the function of activating signals in KO mice limited to suppressing parasitemia by either CMI or AMI. P. Chabaudi infection of KO mice provides an excellent model for studying these signals because it allows dissecting of the controlling signals that regulate the participation of AMI and CMI, both of which participate in protective immunity against both this murine malarial parasite and human P. Falciparum. The results of this proposed research will provide profiles of T cell and macrophage activation predictive of the out come of infection and reveal the cellular and molecular mechanisms of immunity that may serve as targets for immunoprophylaxis and/or immunotherapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI012710-24
Application #
6169363
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Program Officer
Hall, B Fenton
Project Start
1975-06-01
Project End
2003-05-31
Budget Start
2000-06-01
Budget End
2001-05-31
Support Year
24
Fiscal Year
2000
Total Cost
$369,517
Indirect Cost
Name
University of Wisconsin Madison
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Weidanz, W P; Lafleur, G; Kita-Yarbro, A et al. (2011) Signalling through the IL-2 receptor ?(c) peptide (CD132) is essential for the expression of immunity to Plasmodium chabaudi adami blood-stage malaria. Parasite Immunol 33:512-6
Weidanz, William P; LaFleur, GayeLyn; Brown, Andrew et al. (2010) Gammadelta T cells but not NK cells are essential for cell-mediated immunity against Plasmodium chabaudi malaria. Infect Immun 78:4331-40
Lynch, Michelle M; Cernetich-Ott, Amy; Weidanz, William P et al. (2009) Prediction of merozoite surface protein 1 and apical membrane antigen 1 vaccine efficacies against Plasmodium chabaudi malaria based on prechallenge antibody responses. Clin Vaccine Immunol 16:293-302
van der Heyde, Henri C; Burns, James M; Weidanz, William P et al. (2007) Analysis of antigen-specific antibodies and their isotypes in experimental malaria. Cytometry A 71:242-50
van der Heyde, Henri C; Batchelder, Joan M; Sandor, Matyas et al. (2006) Splenic gammadelta T cells regulated by CD4+ T cells are required to control chronic Plasmodium chabaudi malaria in the B-cell-deficient mouse. Infect Immun 74:2717-25
Weidanz, William P; Batchelder, Joan M; Flaherty, P et al. (2005) Plasmodium chabaudi adami: use of the B-cell-deficient mouse to define possible mechanisms modulating parasitemia of chronic malaria. Exp Parasitol 111:97-104
Rummel, Thomas; Batchelder, Joan; Flaherty, Patrick et al. (2004) CD28 costimulation is required for the expression of T-cell-dependent cell-mediated immunity against blood-stage Plasmodium chabaudi malaria parasites. Infect Immun 72:5768-74
Gillman, Brad M; Batchelder, Joan; Flaherty, Patrick et al. (2004) Suppression of Plasmodium chabaudi parasitemia is independent of the action of reactive oxygen intermediates and/or nitric oxide. Infect Immun 72:6359-66
Cigel, Francine; Batchelder, Joan; Burns Jr, James M et al. (2003) Immunity to blood-stage murine malarial parasites is MHC class II dependent. Immunol Lett 89:243-9
Batchelder, Joan M; Burns Jr, James M; Cigel, Francine K et al. (2003) Plasmodium chabaudi adami: interferon-gamma but not IL-2 is essential for the expression of cell-mediated immunity against blood-stage parasites in mice. Exp Parasitol 105:159-66

Showing the most recent 10 out of 36 publications